Abstract | BACKGROUND: RESULTS: More immune cells expressed TLR2 in carcinoma and dysplasia than in hyperplasia (P<0.001). No hyperplastic samples showed positive TLR2 staining on keratinocytes, whereas keratinocytes in 64% of cases of carcinoma and 74% of cases of dysplasia were TLR2 positive. CONCLUSION: Positive TLR2 expression in the microenvironment suggests activation of immune surveillance against the altered epithelium, whereas TLR2 expression by malignant keratinocytes may be indicative of resistance to apoptosis as a pro-survival mechanism.
|
Authors | L K Ng, A M Rich, H M Hussaini, W M Thomson, A L Fisher, L S Horne, G J Seymour |
Journal | British journal of cancer
(Br J Cancer)
Vol. 104
Issue 3
Pg. 460-3
(Feb 01 2011)
ISSN: 1532-1827 [Electronic] England |
PMID | 21179035
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Carcinoma, Squamous Cell
(metabolism, pathology)
- Epithelium
(metabolism, pathology)
- Humans
- Immunohistochemistry
- Keratinocytes
(metabolism)
- Mouth Mucosa
(metabolism, pathology)
- Mouth Neoplasms
(metabolism, pathology)
- Toll-Like Receptor 2
(biosynthesis)
|